Filing Details
- Accession Number:
- 0001237899-11-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-02 18:12:59
- Reporting Period:
- 2011-04-29
- Filing Date:
- 2011-05-02
- Accepted Time:
- 2011-05-02 18:12:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225473 | G Alfred Gilman | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-29 | 20,000 | $0.00 | 31,875 | No | 4 | C | Direct | |
| Common Stock | Disposition | 2011-05-02 | 15,675 | $50.68 | 16,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-02 | 4,325 | $51.11 | 11,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | Disposition | 2011-04-29 | 20,000 | $0.00 | 20,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,237 | No | 4 | C | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 15,675 shares of Company stock on May 2, 2011 at prices ranging from $50.39 to $50.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 2, 2011 at each separate price.
- The reporting person sold 4,325 shares of Company stock on May 2, 2011 at prices ranging from $51.00 to $51.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 2, 2011 at each separate price.
- An exercise date, exercise price, purchase price, sales price and expiration date are not applicable in this case.
Billionaire Hedge Funds
